Global Myelodysplastic Syndrome (MDS) Treatment Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Drug;

Lenalidomide, Decitabine, Azacitidine and Phase 3 Drugs.

Segmented by Route of Administration;

Injection and Oral.

Segmented by Distribution Channel;

Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn118516543 Published Date: March, 2024 Updated Date: April, 2024

Introduction

Global Myelodysplastic Syndrome (MDS) Treatment Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 90.2
2021 106.6
2022 121.9
2023 143.7
2024 153.6
2025 161.8
2026 186.2
2027 214.0
2028 217.0
2029 241.2
2030 249.7

In the year 2023, the Global Myelodysplastic Syndrome (MDS) Treatment Market was valued at USD 2,411.95 million. The size of this market is expected to increase to USD 4,075.07 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.8%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Myelodysplastic Syndrome (MDS) Treatment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Myelodysplastic Syndrome (MDS) Treatment Market, By Drug, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Lenalidomide
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Decitabine
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Azacitidine
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Phase 3 Drugs
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Myelodysplastic Syndrome (MDS) Treatment Market, By Route of Administration, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Injection
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Oral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Myelodysplastic Syndrome (MDS) Treatment Market, By Distribution Channel, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Hospital Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Retail Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Online Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    4. Global Myelodysplastic Syndrome (MDS) Treatment Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Celgene Corporation
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Otsuka Pharmaceutical Co., Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Teva Pharmaceutical Industries Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Sun Pharmaceutical Industries Limited
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Dr. Reddy's Laboratories Ltd.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Mylan NV
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Cipla Limited
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Acceleron Pharma, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Medical Devices Nebulizer
Global Nebulizer Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Nebulizer Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Nanopharmaceuticals
Global Nanopharmaceuticals Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Nanopharmaceuticals Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Narcolepsy Drugs
Global Narcolepsy Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Narcolepsy Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Natural Killer Cells Therapeutics
Global Natural Killer Cells Therapeutics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Natural Killer Cells Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...